poisar

Stocks · News reference

Ocular Therapeutix Announces Participation in November 2026 Investor and Scientific Conferences

Fiscal.ai

Ocular Therapeutix, Inc. announced its upcoming participation in several investor and scientific conferences scheduled for November 2026, including a fireside chat at the UBS Global Biopharma Conference.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaEarnings Transcripts

    Ocular Therapeutix Q3 2026 Earnings Call Transcript

    Ocular Therapeutix (NASDAQ:OCUL) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga

  2. SEC EDGARSEC EDGAR

    8-K filing — OCULAR THERAPEUTIX, INC (OCUL)

    Filed: 2026-11-09 AccNo: 0001104659-26-124159 Size: 191 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers